Theravance Biopharma TBPH
TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Current Taxes (2014 - 2026)

Updated

Theravance Biopharma (TBPH) recorded Current Taxes of $5.29 million in Q1 2026, down 9.7% from $5.85 million a year earlier and unchanged from the prior quarter.

Analysis

Theravance Biopharma (TBPH) Current Taxes (2014 - 2026) Analysis & Trends

Starting with Q3 2014, Theravance Biopharma's Current Taxes history includes 7 quarters.

  • Across earlier years, Current Taxes came in at $5.85 million in FY2024.
  • Quarterly Current Taxes has ranged from $4.07 million in Q3 2025 to $26.7 million in Q2 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $5.29 million (Q4 2025), $4.07 million (Q3 2025) and $26.7 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,129.91 Bn 1,098.50 Bn 19.71 Bn -
2 Johnson & Johnson 613.69 Bn 532.22 Bn 17.26 Bn 1.05 Bn
3 AbbVie 503.05 Bn 476.16 Bn 12.70 Bn -
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 261.30 Bn 234.99 Bn 12.86 Bn 1.47 Bn
7 Amgen 235.86 Bn 191.25 Bn 7.24 Bn -
8 Gilead Sciences 190.51 Bn 164.71 Bn 6.22 Bn -
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn 653.00 Mn
10 Theravance Biopharma 883.70 Mn -543.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5.29 Mn
Dec 31, 2025 5.29 Mn
Sep 30, 2025 4.07 Mn
Jun 30, 2025 26.70 Mn
Mar 31, 2025 5.85 Mn
Dec 31, 2024 5.85 Mn
Sep 30, 2014 5.22 Mn
API Access

Theravance Biopharma Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=TBPH&period=max&api_key=YOUR_API_KEY